Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Release of insulin produced by the choroid plexis is regulated by serotonergic signaling
Caio Henrique Mazucanti, Qing-Rong Liu, Doyle Lang, Nicholas Huang, Jennifer F. O’Connell, Simonetta Camandola, Josephine M. Egan
Caio Henrique Mazucanti, Qing-Rong Liu, Doyle Lang, Nicholas Huang, Jennifer F. O’Connell, Simonetta Camandola, Josephine M. Egan
View: Text | PDF
Research Article Endocrinology Neuroscience

Release of insulin produced by the choroid plexis is regulated by serotonergic signaling

  • Text
  • PDF
Abstract

The choroid plexus (ChP) is a highly vascularized tissue found in the brain ventricles, with an apical epithelial cell layer surrounding fenestrated capillaries. It is responsible for the production of most of the cerebrospinal fluid (CSF) in the ventricular system, subarachnoid space, and central canal of the spinal cord, while also constituting the blood-CSF barrier (BCSFB). In addition, epithelial cells of the ChP (EChP) synthesize neurotrophic factors and other signaling molecules that are released into the CSF. Here, we show that insulin is produced in EChP of mice and humans, and its expression and release are regulated by serotonin. Insulin mRNA and immune-reactive protein, including C-peptide, are present in EChP, as detected by several experimental approaches, and appear in much higher levels than any other brain region. Moreover, insulin is produced in primary cultured mouse EChP, and its release, albeit Ca2+ sensitive, is not regulated by glucose. Instead, activation of the 5HT2C receptor by serotonin treatment led to activation of IP3-sensitive channels and Ca2+ mobilization from intracellular storage, leading to insulin secretion. In vivo depletion of brain serotonin in the dorsal raphe nucleus negatively affected insulin expression in the ChP, suggesting an endogenous modulation of ChP insulin by serotonin. Here, we show for the first time to our knowledge that insulin is produced by EChP in the brain, and its release is modulated at least by serotonin but not glucose.

Authors

Caio Henrique Mazucanti, Qing-Rong Liu, Doyle Lang, Nicholas Huang, Jennifer F. O’Connell, Simonetta Camandola, Josephine M. Egan

×

Figure 4

Serotonin causes intracellular Ca2+ oscillation in cultured choroid plexus primary epithelial cells.

Options: View larger image (or click on image) Download as PowerPoint
Serotonin causes intracellular Ca2+ oscillation in cultured choroid plex...
(A) In culture, epithelial cells of the choroid plexus form tight junctions, as shown by ZO-1 staining (red), and insulin and C-peptide are still detectable (green). Scale bars: 20 μm. (B) Glucose had no effect on iCa2+ levels, as shown by live cell Ca2+. (C and D) Serotonin, on the other hand, induced an acute intracellular increase (average peak intensity of 2.951 times higher than baseline, SEM = 0.135, n = 87, 8 independent experiments). Extracellular Ca2+ was not necessary for such effect (average peak intensity of 3.757 times higher than baseline, SEM = 0.144, n = 96, 7 independent experiments), as evidenced by equal AUC of responses with or without extracellular Ca2+ (cells with extracellular Ca2+: total peak area = 249.5; standard error = 17.99; 95% CI, 214.3–284.8; and cells without extracellular Ca2+: total peak area = 269.3; SEM = 19.68; 95% CI, 230.8–307.9; t test p value = 0.4596). Scale bars: 20 μm. (E) Pharmacological antagonism of IP3R with 2APB, or membrane serotonin receptor 5HT2C with RS 102221, completely blocked the serotonin-induced Ca2+ increase in these cells.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts